JP2021511388A5 - - Google Patents

Info

Publication number
JP2021511388A5
JP2021511388A5 JP2020561603A JP2020561603A JP2021511388A5 JP 2021511388 A5 JP2021511388 A5 JP 2021511388A5 JP 2020561603 A JP2020561603 A JP 2020561603A JP 2020561603 A JP2020561603 A JP 2020561603A JP 2021511388 A5 JP2021511388 A5 JP 2021511388A5
Authority
JP
Japan
Prior art keywords
skin
ceramide
reduce
composition according
appearance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020561603A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021511388A (ja
JP7369716B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/015137 external-priority patent/WO2019147931A1/en
Publication of JP2021511388A publication Critical patent/JP2021511388A/ja
Publication of JP2021511388A5 publication Critical patent/JP2021511388A5/ja
Application granted granted Critical
Publication of JP7369716B2 publication Critical patent/JP7369716B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020561603A 2018-01-26 2019-01-25 皮膚バリア機能を改善するためのアンブロキソールの使用 Active JP7369716B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862622375P 2018-01-26 2018-01-26
US62/622,375 2018-01-26
PCT/US2019/015137 WO2019147931A1 (en) 2018-01-26 2019-01-25 Use of ambroxol to improve skin barrier function

Publications (3)

Publication Number Publication Date
JP2021511388A JP2021511388A (ja) 2021-05-06
JP2021511388A5 true JP2021511388A5 (cg-RX-API-DMAC7.html) 2022-01-12
JP7369716B2 JP7369716B2 (ja) 2023-10-26

Family

ID=65363412

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020561603A Active JP7369716B2 (ja) 2018-01-26 2019-01-25 皮膚バリア機能を改善するためのアンブロキソールの使用

Country Status (6)

Country Link
US (3) US10894008B2 (cg-RX-API-DMAC7.html)
EP (1) EP3743039A1 (cg-RX-API-DMAC7.html)
JP (1) JP7369716B2 (cg-RX-API-DMAC7.html)
CN (1) CN111655223A (cg-RX-API-DMAC7.html)
CA (1) CA3087079A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019147931A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3654960A1 (en) * 2017-07-16 2020-05-27 Neuere, LLC Ambroxol to improve and/or extend healthspan, lifespan and/or mental acuity
WO2019147931A1 (en) * 2018-01-26 2019-08-01 Neuere, Llc Use of ambroxol to improve skin barrier function
WO2022098366A1 (en) * 2020-11-09 2022-05-12 Redwood Ip Holding, Llc Skincare compositions for preventing transepidermal water loss
WO2022264148A1 (en) * 2021-06-16 2022-12-22 Lycored Ltd. Compositions and methods for improving skin barrier
US20250161255A1 (en) * 2022-01-25 2025-05-22 Motoshi Hayano New therapy and prevention for suppressing aging-related disorders including sarcopenia
KR20260002803A (ko) * 2023-05-02 2026-01-06 지위, 엘엘씨 치료적 사용을 위한 암브록솔의 변형된 형태

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20012038A3 (cs) * 1998-12-23 2001-09-12 Idea Ag Zdokonalený přípravek pro topické, neinvazivní použití in vivo
IL160539A0 (en) 2001-09-04 2004-07-25 Boehringer Ingelheim Int Anti-influenzal agents
DE10332487A1 (de) 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung von chronisch nozizeptiven Schmerzen
DE102004021992A1 (de) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topische Zubereitung enthaltend Ambroxol
JP2008520630A (ja) 2004-11-22 2008-06-19 シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト 皮膚損傷に有効なセラミド及び/又は偽セラミドと(α−)ビサボロールを含む製剤
CN101583346B (zh) 2006-04-28 2015-08-19 儿童医院医疗中心 用于穿膜药物递送系统的皂化蛋白c和相关蛋白及肽的促融合性质
BRPI0714256A2 (pt) * 2006-08-09 2013-06-18 Takasago Internat Corp U S A composiÇço tàpica, formulaÇço tàpica, mÉtodo para preparar uma composiÇço tàpica, mÉtodo para tratar uma condiÇço de pele, mÉtodo para tratar uma irritaÇço de pele e mÉtodo para fortalecer, firmar, rejuvenescer ou restaurar a condiÇço da pele
JP5337405B2 (ja) 2007-09-17 2013-11-06 ザ・ホスピタル・フォー・シック・チルドレン ゴーシェ病の治療方法
US20110294833A1 (en) 2010-05-26 2011-12-01 Scripps Health Methods for Healthy Aging
JP5938193B2 (ja) 2011-11-10 2016-06-22 ポーラ化成工業株式会社 抗老化剤のスクリ−ニング方法
BR112014012858B1 (pt) * 2011-11-30 2019-02-26 Ibr - Israeli Biotechnology Research Ltd. Extrato de jojoba útil em melhorar as funções de barreira da pele
JP2013241398A (ja) 2012-04-27 2013-12-05 Fujifilm Corp β−グルコセレブロシダーゼ活性増強剤、セラミド産生増強剤及び皮膚バリア機能改善剤
TW201422246A (zh) 2012-12-11 2014-06-16 Avon Prod Inc 藉由調節wipi-1改善皮膚老化外觀之方法
US20180296464A1 (en) 2017-04-17 2018-10-18 W Skincare, LLC Autophagy activation nutrient complex, compositions and methods
US10179095B2 (en) 2017-06-07 2019-01-15 Dr. Raymond Laboratories Autophage activating resveratrol topical composition for skin improvement and treatment
EP3654960A1 (en) * 2017-07-16 2020-05-27 Neuere, LLC Ambroxol to improve and/or extend healthspan, lifespan and/or mental acuity
WO2019147931A1 (en) * 2018-01-26 2019-08-01 Neuere, Llc Use of ambroxol to improve skin barrier function

Similar Documents

Publication Publication Date Title
AU2016202140B2 (en) Compositions for skin exfoliation and use thereof
EP3713583B1 (en) Methods and compositions for treatment of skin
RU2113216C1 (ru) Косметический состав (варианты)
TW201513853A (zh) 用於表皮修復和皮膚疾患治療的配方
HU218914B (hu) Eljárás cellulitis kezelésére alkalmas,hatóanyagként retinsavat vagy annak valamely sóját vagy retinolt tartalmazó gyógyszerkészítmények előállítására
WO2017100873A1 (pt) Composição cosmética e seu uso
JP4955382B2 (ja) 抗アレルギ作用及び抗炎症作用を有する表皮剥離性組成
US20200030398A1 (en) Skin care composition
US20020176876A1 (en) Topical therapeutic skin care system
KR20250163412A (ko) 스트론튬 및 메틸술포닐메탄(msm)을 포함하는 국소 제제 및 치료 방법
US12440508B2 (en) Methods and compositions for therapeutic skin treatments in dermatological procedures affecting skin's barrier
EP3195852A1 (en) Keratin softening patch
JP2013531664A (ja) Spf30を有する保湿組成物
RU2722823C2 (ru) Косметический состав для лечения и профилактики акне на коже
JP2016501236A (ja) 炎症性皮膚状態の予防および治療のための方法
JPH11505238A (ja) 皮膚症状処置用組成物
EP3378474B1 (en) Composition for the use in the treatment of plantar hyperhidrosis predisposing to cutaneous fungal infection of the foot
US20040204492A1 (en) Topical composition and method for treating seborrheic dermatitis
US20240207345A1 (en) Methods and compositions for treating hair loss
JP2026506380A (ja) 皮膚の状態または疾患を処置する方法
Stough et al. New beneficial agents in the treatment of acne vulgaris and seborrheic dermatitis
KR20140118321A (ko) 유황, 명반 및 식초를 유효성분으로 포함하는 피부 질환 치료용 조성물
KR19990009254A (ko) 나이아신을 함유한 모발샴푸 조성물
HK40038584A (en) Methods and compositions for treatment of skin
HK40038584B (en) Methods and compositions for treatment of skin